CSF2 and psoriasis vulgaris: The present investigation was performed to evaluate the therapeutic potential of GM-CSF blockade in the treatment of psoriasis by assessing the effect of an anti-murine GM-CSF monoclonal antibody (mAb) in the imiquimod (IMQ)-induced psoriasiform dermatitis (IMQPD) mouse model of plaque psoriasis.